DongKoo Bio & Pharma Co. Ltd. Free Cash Flow Generation Index
DongKoo Bio & Pharma Co. Ltd. free cash flow generation index. DongKoo Bio & Pharma Co. Ltd. (006620) has a Free Cash Flow Generation Index of -0.17x as of June 2026. Free cash flow of ₩-756.72 Million represents 0% of operating cash flow (₩4.46 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of DongKoo Bio & Pharma Co. Ltd. (2015–2024)
Free cash flow generation index of DongKoo Bio & Pharma Co. Ltd. from 2015 to 2024. Historical FCF Generation Index trend for DongKoo Bio & Pharma Co. Ltd. across 9 annual periods. See 006620 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
DongKoo Bio & Pharma Co. Ltd. Free Cash Flow Generation Index by Year (2015–2024)
DongKoo Bio & Pharma Co. Ltd. free cash flow generation index by year from 2015 to 2024. Year-by-year Free Cash Flow Generation Index for DongKoo Bio & Pharma Co. Ltd.. For the full cash flow conversion analysis, see how efficiently does DongKoo Bio & Pharma Co. Ltd. generate cash.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.47x | ₩-8.12 Billion | ₩17.34 Billion | ₩25.46 Billion | ▲ +86.4% |
| 2023 | -3.45x | ₩-12.38 Billion | ₩3.59 Billion | ₩15.97 Billion | ▼ -1111.1% |
| 2022 | 0.34x | ₩5.74 Billion | ₩16.82 Billion | ₩11.08 Billion | ▼ -50.8% |
| 2021 | 0.69x | ₩12.43 Billion | ₩17.90 Billion | ₩4.27 Billion | ▲ +156.3% |
| 2020 | 0.27x | ₩2.03 Billion | ₩7.49 Billion | ₩5.27 Billion | ▲ +208.5% |
| 2019 | -0.25x | ₩-2.53 Billion | ₩10.14 Billion | ₩8.77 Billion | ▼ -123.0% |
| 2017 | 1.09x | ₩10.32 Billion | ₩9.51 Billion | ₩810.51 Million | ▼ -28.6% |
| 2016 | 1.52x | ₩19.14 Billion | ₩12.59 Billion | ₩6.55 Billion | ▲ +14.0% |
| 2015 | 1.33x | ₩9.25 Billion | ₩6.93 Billion | ₩2.32 Billion | — |